glp 1 companies to invest in GLP-1 Drugs Market Size Hit USD 132.79 Bn by 2035 GLP-1 Drugs Drop More Than

IQVIA data shows that as of Q1 2025, Eli Lilly (including tirzepatide, dulaglutide and other related products) has increased its total prescription volume in the US incretin analog market to 53.3%, surpassing its main competitor, Novo Nordisk

We continue to believe it is appropriate to subject the diagnostic radiopharmaceutical packaging threshold to the same update factor that is used for the OPPS drug packaging threshold as supported by the majority of commenters

This allows the body to absorb and utilize the glutathione more efficiently than it would through oral supplements

However, Aetna may offer GLP-1 coverage for weight management programs under certain conditions if the employer or an employer-sponsored benefits plan chooses to include it, often with strict requirements, such as prior authorization tied to body mass index (BMI) and other health conditions